22-42086285-TTTAA-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_002490.6(NDUFA6):c.281_284del(p.Ile94LysfsTer44) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000589 in 1,614,116 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000062 ( 0 hom. )
Consequence
NDUFA6
NM_002490.6 frameshift
NM_002490.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.40
Genes affected
NDUFA6 (HGNC:7690): (NADH:ubiquinone oxidoreductase subunit A6) This gene encodes a member of the LYR family of proteins that contain a highly conserved tripeptide (LYR) motif near the N-terminus. The encoded protein is an accessory subunit of NADH: ubiquinone oxidorerductase (Complex I), which is the largest enzyme of the mitochondrial membrane respiratory chain. Complex I functions in electron transfer from NADH to the respiratory chain. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.274 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 22-42086285-TTTAA-T is Pathogenic according to our data. Variant chr22-42086285-TTTAA-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1324784.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NDUFA6 | NM_002490.6 | c.281_284del | p.Ile94LysfsTer44 | frameshift_variant | 3/3 | ENST00000498737.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NDUFA6 | ENST00000498737.8 | c.281_284del | p.Ile94LysfsTer44 | frameshift_variant | 3/3 | 1 | NM_002490.6 | P1 | |
NDUFA6 | ENST00000617763.1 | c.359_362del | p.Ile120LysfsTer44 | frameshift_variant | 3/3 | 1 | |||
NDUFA6 | ENST00000470753.1 | c.110_113del | p.Ile37LysfsTer44 | frameshift_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152258Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
5
AN:
152258
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000795 AC: 20AN: 251474Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135918
GnomAD3 exomes
AF:
AC:
20
AN:
251474
Hom.:
AF XY:
AC XY:
8
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000616 AC: 90AN: 1461858Hom.: 0 AF XY: 0.0000591 AC XY: 43AN XY: 727224
GnomAD4 exome
AF:
AC:
90
AN:
1461858
Hom.:
AF XY:
AC XY:
43
AN XY:
727224
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152258Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74394
GnomAD4 genome
AF:
AC:
5
AN:
152258
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
74394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 18, 2022 | The c.359_362delTTAA (p.I120Kfs*44) alteration, located in exon 3 (coding exon 3) of the NDUFA6 gene, consists of a deletion of 4 nucleotides from position 359 to 362, causing a translational frameshift with a predicted alternate stop codon after 44 amino acids. This alteration occurs at the 3' terminus of the NDUFA6 gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 22% of the protein. Premature stop codons are typically deleterious in nature and a significant portion of the protein is affected (Ambry internal data). Based on data from gnomAD, this alteration has an overall frequency of 0.01% (20/251474) total alleles studied. The highest observed frequency was 0.01% (5/34592) of Latino alleles. Based on the available evidence, this alteration is classified as likely pathogenic. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 12, 2022 | This sequence change creates a premature translational stop signal (p.Ile120Lysfs*44) in the NDUFA6 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 35 amino acid(s) of the NDUFA6 protein. This variant is present in population databases (rs768463498, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with NDUFA6-related conditions. This variant is also known as c22_42482290: del_TTAA. ClinVar contains an entry for this variant (Variation ID: 1324784). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at